Journal article · 2026 · Open access
Maternal Respiratory Syncytial Virus Prefusion F Vaccination and Acute Respiratory Illness in Infants
JAMA Network Open, 9(6), e2616773 · Published 5 June 2026 · DOI 10.1001/jamanetworkopen.2026.16773
In brief
“Maternal Respiratory Syncytial Virus Prefusion F Vaccination and Acute Respiratory Illness in Infants” is a 2026 journal article by Anne-Marie Rick and 18 co-authors, published in JAMA Network Open. OpenAlex counts 7 citations as of 18 November 2026, which puts it in the top 2% of works published in 2026 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at JAMA Network Open.
- Citations
- 7
- Most cited in
- 2026 (7)
- Field-weighted impact
- 23.29
- References
- 18
- Authors
- 19
Abstract
Importance: The bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine was licensed in the US in September 2023 to prevent RSV-associated lower respiratory tract disease (LRTD) in infants via maternal immunization. Clinical data on vaccine effectiveness are limited. Objective: To estimate the effectiveness of maternal RSVpreF vaccination against hospitalization for RSV-associated acute respiratory illness (ARI) and LRTD among infants 90 days or younger during the first 2 postlicensure RSV seasons. Design, Setting, and Participants: This retrospective case-control study (Effectiveness of ABRYSVO Maternal Respiratory Syncytial Virus Vaccine Against RSV in Infants in Western Pennsylvania study) using a test-negative design was conducted within a single health system in western Pennsylvania during the 2023-2024 and 2024-2025 RSV seasons. The analysis included infants 90 days or younger born between October 1, 2023, and April 15, 2024, or between September 1, 2024, and April 30, 2025, who were hospitalized with ARI and tested for RSV using nucleic acid amplification or rapid antigen testing. Exposure: Maternal RSVpreF vaccination administered at gestational age between 32 weeks 0 to 7 days and 36 weeks 6 to 7 days and at least 14 days before delivery. Main Outcomes and Measures: The primary outcome was RSV-associated ARI requiring hospitalization. The secondary outcome was RSV-associated LRTD requiring hospitalization. Vaccine effectiveness was estimated as (1 - Adjusted Odds Ratio) × 100% comparing the odds of maternal RSVpreF vaccination among RSV-positive infants (cases) vs RSV-negative infants (controls) using multivariable logistic regression. Results: Among 274 included infants (83 with RSV and 191 controls), the mean (SD) age at admission was 29.5 (21.1) days; 143 infants (52.2%) were male. Among these, 11 of 83 infants with RSV (13.3%) and 71 of 191 controls (37.2%) were born to RSVpreF-vaccinated individuals. Vaccine effectiveness was estimated to be 67.6% (95% CI, 33.2%-85.4%) against RSV-associated ARI hospitalization and 69.0% (95% CI, 25.5%-88.0%) against RSV-associated LRTD hospitalization from 0 through 90 days of age. Among infants aged 0 to 30 days, vaccine effectiveness against RSV-associated ARI hospitalization was estimated to be 74.2% (95% CI, 25.4%-93.0%). Conclusions and Relevance: Maternal RSVpreF vaccination was associated with protection against RSV-associated ARI and LRTD hospitalization among infants 90 days or younger. These findings provide early clinical evidence supporting the effectiveness of maternal RSVpreF vaccination in preventing RSV-associated hospitalization in infants.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Rick, A.-M., Deese, J., Kerr, J., Hui, J., Liu, H., Yu, G., Chang, C.-C. H., Fazio, N., Tahir, M. H., Bieltz, R., Ravindra, A., Megli, C., Jeyabalan, A., Pugh, S. J., Patel, D., Fan, R., Atwell, J. E., Cane, A. D., & Martin, J. M. (2026). Maternal Respiratory Syncytial Virus Prefusion F Vaccination and Acute Respiratory Illness in Infants. JAMA Network Open, 9(6), e2616773. https://doi.org/10.1001/jamanetworkopen.2026.16773
MLA 9
Rick, Anne-Marie, et al. “Maternal Respiratory Syncytial Virus Prefusion F Vaccination and Acute Respiratory Illness in Infants.” JAMA Network Open, vol. 9, no. 6, 2026, p. e2616773. https://doi.org/10.1001/jamanetworkopen.2026.16773.
Chicago
Rick, Anne-Marie, Jennifer Deese, Jessica Kerr, Jonathan Hui, Hui Liu, Guan Yu, Chung-Chou H. Chang, et al. 2026. “Maternal Respiratory Syncytial Virus Prefusion F Vaccination and Acute Respiratory Illness in Infants.” JAMA Network Open 9 (6): e2616773. https://doi.org/10.1001/jamanetworkopen.2026.16773.
Harvard
Rick, A.-M. et al. (2026) ‘Maternal Respiratory Syncytial Virus Prefusion F Vaccination and Acute Respiratory Illness in Infants’, JAMA Network Open, 9(6), p. e2616773. doi:10.1001/jamanetworkopen.2026.16773.
IEEE
A.-M. Rick et al., “Maternal Respiratory Syncytial Virus Prefusion F Vaccination and Acute Respiratory Illness in Infants,” JAMA Network Open, vol. 9, no. 6, p. e2616773, 2026, doi: 10.1001/jamanetworkopen.2026.16773.
BibTeX
@article{rick2026maternal,
title = {{Maternal Respiratory Syncytial Virus Prefusion F Vaccination and Acute Respiratory Illness in Infants}},
author = {Rick, Anne-Marie and Deese, Jennifer and Kerr, Jessica and Hui, Jonathan and Liu, Hui and Yu, Guan and Chang, Chung-Chou H. and Fazio, Nicole and Tahir, Muhammad H. and Bieltz, Rachael and Ravindra, Anjani and Megli, Christina and Jeyabalan, Arun and Pugh, Sarah J. and Patel, Divya and Fan, Rong and Atwell, Jessica E. and Cane, Alejandro D. and Martin, Judith M.},
journal = {JAMA Network Open},
year = {2026},
volume = {9},
number = {6},
pages = {e2616773},
doi = {10.1001/jamanetworkopen.2026.16773},
url = {https://doi.org/10.1001/jamanetworkopen.2026.16773}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- respiratory syncytial virus
- RSVpreF vaccine
- maternal immunization
- vaccine effectiveness
- acute respiratory illness
- lower respiratory tract disease
- infant hospitalization
- Abrysvo
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Rick, A.-M., Deese, J., Kerr, J., Hui, J., Liu, H., Yu, G., Chang, C.-C. H., Fazio, N., Tahir, M. H., Bieltz, R., Ravindra, A., Megli, C., Jeyabalan, A., Pugh, S. J., Patel, D., Fan, R., Atwell, J. E., Cane, A. D., & Martin, J. M. (2026). Maternal Respiratory Syncytial Virus Prefusion F Vaccination and Acute Respiratory Illness in Infants. JAMA Network Open, 9(6), e2616773. https://doi.org/10.1001/jamanetworkopen.2026.16773
How many times has this paper been cited?
7 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at JAMA Network Open: sign in and open the full text from this page.
Who wrote this paper?
Anne-Marie Rick, Jennifer Deese, Jessica Kerr, Jonathan Hui, Hui Liu, Guan Yu, Chung-Chou H. Chang, Nicole Fazio, Muhammad H. Tahir, Rachael Bieltz, Anjani Ravindra, Christina Megli and 7 more.
What is the DOI of this paper?
10.1001/jamanetworkopen.2026.16773, permanently at https://doi.org/10.1001/jamanetworkopen.2026.16773. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.